Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2020

View Archived Issues

First multitope peptide-based vaccine against SARS-CoV-2 to enter clinical testing

Blood infrastructure problems contribute to ASD

Everyone's an immune cell

c-Myc overexpression used to create mouse-derived allograft model of hepatocellular carcinoma

SBIR grant supports Lamassu's development of RABI-767 for acute pancreatitis

Chinese clearance for global phase III trial of catumaxomab for peritoneal carcinomatosis

HFB-200301 shows potential as novel immunotherapeutic agent in vivo

BPI-28592, a novel potent next-generation TRK kinase inhibitor

Nexys Therapeutics presents new ALK5 inhibitors

Praxis Precision Medicines patents compounds targeting human KCNT1

SPRY1 targeting useful for treating BRAF V600-mutant cutaneous melanoma

Recce and Path BioAnalytics collaborate in expanded SARS-CoV-2 program

Surface Oncology describes preclinical activity of anti-PVRIG antibody SRF-813

Bcl-2/Bcl-xl dual inhibitor AZD-0466 shows promise for treating ALL

Heron initiates phase II GUARDS-1 study of Cinvanti for the treatment of COVID-19

Binding of MAO-A PET radiotracer [18F]FAZIN-3 observed in Parkinson's, Alzehimer's brain samples

NIH grant supports development of Vivasc's CTP-amio for arrhythmia

Dynavax and Mount Sinai collaborate to develop a universal influenza vaccine

Phase III trial begins in UAE for Sinopharm's inactivated vaccine for COVID-19

Xenleta approved in Canada for community-acquired pneumonia

Tracon files pivotal ENVASARC protocol with the FDA

Expansion of phase I study evaluating eprenetapopt in TP53-mutant AML

[18F]-FSPG PET can rule out cardiac sarcoidosis after nondiagnostic [18F]-FDG PET

Samus opens phase IIa trial of PU-AD for mild Alzheimer's disease dementia

Lilly reports OASIS-2 data with mirikizumab in moderate to severe plaque psoriasis

Celltrion advances antiviral antibody treatment for COVID-19 into phase I

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...